Chalkis Health Industry Co., Ltd

Symbol: 000972.SZ

SHZ

3.12

CNY

Market price today

  • 24.8806

    P/E Ratio

  • 0.2262

    PEG Ratio

  • 2.41B

    MRK Cap

  • 0.00%

    DIV Yield

Chalkis Health Industry Co., Ltd (000972-SZ) Stock Price & Analysis

Shares Outstanding

0M

Gross Profit Margin

0.24%

Operating Profit Margin

0.09%

Net Profit Margin

0.18%

Return on Assets

0.09%

Return on Equity

0.57%

Return on Capital Employed

0.16%

Company general description and statistics

Sector: Consumer Defensive
Industry: Packaged Foods
CEO:Mr. Yanxun Zhuang
Full-time employees:585
City:Wujiaqu
Address:No. 2666, Courtyard Room Hotel
IPO:2000-09-26
CIK:

Chalkis Health Industry Co., Ltd. produces, processes, and sells tomatoes worldwide. It offers tomato paste concentrated in drums and wooden bins, peeled and diced tomatoes, canned tomato products, tomato fiber sheets, and tomato seed oil, as well as lycopene capsules. The company was formerly known as Xinjiang Chalkis Co., Ltd. and changed its name to Chalkis Health Industry Co., Ltd. in May 2016. Chalkis Health Industry Co., Ltd. is based in Urumqi, China.

General Outlook

When we look at how much money they make before expenses, they keep 0.244% as profit. This shows they're good at controlling costs and are financially stable. Their operating profit, which is money made from regular business activities, is 0.090%. This means they run their business efficiently. Lastly, after paying all their bills, they still have a profit of 0.179%. This tells us they're good at keeping money after all costs.

Return on Investments

The company's asset efficiency, represented by a robust 0.088% return, is a testament to Chalkis Health Industry Co., Ltd's adeptness in optimizing resource deployment. Chalkis Health Industry Co., Ltd's utilization of its assets to generate profits is strikingly evident through a noteworthy return on equity of 0.569%. Furthermore, the proficiency of Chalkis Health Industry Co., Ltd in capital utilization is underscored by a remarkable 0.160% return on capital employed.

Stock Prices

Chalkis Health Industry Co., Ltd's stock prices have been subject to undulating patterns. The peak stock value during this interval surged to $3.68, while its low point bottomed out at $3.57. This variance in figures offers investors a lucid insight into the roller-coaster ride that is Chalkis Health Industry Co., Ltd's stock market.

Liquidity Ratios

Analyzing 000972.SZ liquidity ratios reveals its financial health of the firm. The current ratio of 83.61% gauges short-term asset coverage for liabilities. The quick ratio (10.45%) assesses immediate liquidity, while the cash ratio (4.92%) indicates cash reserves.

cards.indicatorcards.value
Current Ratio83.61%
Quick Ratio10.45%
Cash Ratio4.92%

Profitability Ratios

000972.SZ profitability indicators offer a lens into its earnings landscape. A pretax profit margin of 18.20% underscores its earnings before tax deductions. The effective tax rate stands at 0.26%, revealing its tax efficiency. The net income per EBT, 98.60%, and the EBT per EBIT, 201.65%, provide insights into its earnings hierarchy. Lastly, with an EBIT per revenue ratio of 9.03%, we grasp its operational profitability.

cards.indicatorcards.value
Pretax Profit Margin18.20%
Effective Tax Rate0.26%
Net Income per EBT98.60%
EBT per EBIT201.65%
EBIT per Revenue9.03%

Operational Efficiency

Operational metrics shed light on its business agility. With an operating cycle of 0.84, it details the span from stock purchase to revenue.

cards.indicatorcards.value
Days of Sales Outstanding10
Days of Inventory Outstanding490
Operating Cycle520.18
Days of Payables Outstanding68
Cash Conversion Cycle452
Receivables Turnover12.21
Payables Turnover5.38
Inventory Turnover0.74
Fixed Asset Turnover1.30
Asset Turnover0.49

Cash Flow Ratios

Peering into the cash flow metrics reveals liquidity and operational efficiency. The operating cash flow per share, -0.30, and free cash flow per share, -0.59, depict cash generation on a per-share basis. The cash per share value, 0.05, showcases liquidity position. A payout ratio of 0.25 highlights the portion of earnings distributed as dividends. Lastly, the operating cash flow sales ratio, -0.43, offers insight into cash flow relative to sales.

cards.indicatorcards.value
Operating Cash Flow per Share-0.30
Free Cash Flow per Share-0.59
Cash per Share0.05
Payout Ratio0.25
Operating Cash Flow Sales Ratio-0.43
Free Cash Flow to Operating Cash Flow Ratio1.97
Cash Flow Coverage Ratio-0.61
Short Term Coverage Ratio-0.76
Capital Expenditure Coverage Ratio-1.04
Dividend Paid and Capex Coverage Ratio-0.94
Dividend Payout Ratio0.01

Debt and Leverage Ratios

Diving into debt and leverage metrics unveils the company's financial structure. The debt ratio, at 33.80%, highlights its total liabilities relative to assets. With a debt-equity ratio of 1.79, we discern the balance between debt and equity financing. The long-term debt to capitalization, 25.58%, and total debt to capitalization, 64.16%, ratios shed light on its capital structure. An interest coverage of 1.99 indicates its ability to manage interest expenses.

cards.indicatorcards.value
Debt Ratio33.80%
Debt Equity Ratio1.79
Long Term Debt to Capitalization25.58%
Total Debt to Capitalization64.16%
Interest Coverage1.99
Cash Flow to Debt Ratio-0.61
Company Equity Multiplier5.30

Per Share Data

Speaking about the per share data offers a perceptive view of financial distribution. The revenue per share, 0.74, provides a glimpse into top-line earnings distributed across each share. Net income per share, 0.14, reflects the portion of profit attributed to each share. The book value per share, 0.26, represents the net asset value distributed per share, while the tangible book value per share, 0.27, excludes intangible assets.

cards.indicatorcards.value
Revenue Per Share0.74
Net Income Per Share0.14
Book Value Per Share0.26
Tangible Book Value Per Share0.27
Shareholders Equity Per Share0.26
Interest Debt Per Share0.57
Capex Per Share-0.28

Growth Ratios

Delving into growth metrics provides a snapshot of financial expansion. The revenue growth rate, -3.36%, indicates top-line expansion, while the gross profit growth, -13.89%, reveals profitability trends. EBIT growth, -46.53%, and operating income growth, -46.53%, offer insights into operational profitability progression. The net income growth, 314.94%, showcases bottom-line expansion, and the EPS growth, 314.20%, measures the growth in earnings per share.

cards.indicatorcards.value
Revenue Growth-3.36%
Gross Profit Growth-13.89%
EBIT Growth-46.53%
Operating Income Growth-46.53%
Net Income Growth314.94%
EPS Growth314.20%
EPS Diluted Growth314.20%
Dividends per Share Growth27.53%
Operating Cash Flow Growth-192.15%
Free Cash Flow Growth-317.16%
10-Year Revenue Growth per Share-40.36%
5-Year Revenue Growth per Share-9.20%
3-Year Revenue Growth per Share2379.68%
10-Year Operating CF Growth per Share-152.77%
5-Year Operating CF Growth per Share-143.73%
3-Year Operating CF Growth per Share-1742.77%
10-Year Net Income Growth per Share129.60%
5-Year Net Income Growth per Share123.37%
3-Year Net Income Growth per Share140.58%
10-Year Shareholders Equity Growth per Share344.65%
5-Year Shareholders Equity Growth per Share-53.62%
3-Year Shareholders Equity Growth per Share15.62%
10-Year Dividend per Share Growth per Share-69.86%
3-Year Dividend per Share Growth per Share6714.66%
Receivables Growth-53.04%
Inventory Growth184.36%
Asset Growth48.31%
Book Value per Share Growth113.55%
Debt Growth3298.88%
SGA Expenses Growth459.07%

Other Metrics

Venturing into other key metrics unveils diverse facets of financial performance. The enterprise value, 3,046,371,347.45, captures the company's total value, considering both debt and equity. Income quality, -1.68, assesses the reliability of reported earnings. The sales, general, and administrative to revenue ratio, 0.03, gauges operational efficiency, while the research and development to revenue, 0.15%, highlights investment in innovation. The ratio of intangibles to total assets, 1.28%, indicates the value of non-physical assets, and capex to operating cash flow, 118.86%, measures reinvestment capability.

cards.indicatorcards.value
Enterprise Value3,046,371,347.45
Income Quality-1.68
Sales General and Administrative to Revenue0.03
Research and Development to Revenue0.15%
Intangibles to Total Assets1.28%
Capex to Operating Cash Flow118.86%
Capex to Revenue-38.03%
Capex to Depreciation-527.63%
Graham Number0.91
Return on Tangible Assets8.96%
Graham Net Net-0.70
Working Capital-143,341,833
Tangible Asset Value210,656,461
Net Current Asset Value-215,846,011
Invested Capital2
Average Receivables79,114,530.5
Average Payables96,097,225.5
Average Inventory416,578,001
Days Sales Outstanding32
Days Payables Outstanding87
Days of Inventory On Hand516
ROIC10.49%
ROE0.53%

Valuation Ratios

Exploring the valuation ratios offers insights into perceived market value. The price to book value ratio, 11.56, and the price to book ratio, 11.56, reflect the market's valuation relative to the company's book value. The price to sales ratio, 4.47, provides a perspective on valuation in relation to sales. Ratios like price to free cash flows, -5.35, and price to operating cash flows, -10.51, gauge market valuation against cash flow metrics.

cards.indicatorcards.value
Price Book Value Ratio11.56
Price to Book Ratio11.56
Price to Sales Ratio4.47
Price Cash Flow Ratio-10.51
Price Earnings to Growth Ratio0.23
Enterprise Value Multiple26.53
Price Fair Value11.56
Price to Operating Cash Flow Ratio-10.51
Price to Free Cash Flows Ratio-5.35
Price to Tangible Book Ratio13.45
Enterprise Value to Sales5.35
Enterprise Value Over EBITDA28.62
EV to Operating Cash Flow-16.72
Earnings Yield3.95%
Free Cash Flow Yield-14.57%
security
Trusted project
“All information displayed on the site is verified. High quality project and financial performance”
Eugene Alexeev
NumFin Founder and investing enthusiast

Frequently Asked Question

How many company shares are outstanding in 2024?

There are stock number shares outstanding of Chalkis Health Industry Co., Ltd (000972.SZ) on the SHZ in 2024.

What is P/E ratio of enterprise in 2024?

The current P/E ratio of enterprise is 24.881 in 2024.

What is the ticker symbol of Chalkis Health Industry Co., Ltd stock?

The ticker symbol of Chalkis Health Industry Co., Ltd stock is 000972.SZ.

What is company IPO date?

IPO date of Chalkis Health Industry Co., Ltd is 2000-09-26.

What is company current share price?

Current share price is 3.120 CNY.

What is stock market cap today?

The market cap of stock today is 2406406080.000.

What is PEG ratio in 2024?

The current 0.226 is 0.226 in 2024.

What is the number of employees in 2024?

In 2024 the company has 585.